Trial Details
COMPLETEDBasic Information
| Clinical ID | c4335 |
|---|---|
| Identifier | NCT00679432 |
| Trial Title | (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | PROCEDURE: Blood sampling, endoscopy|DRUG: budesonide-MMX® 6 mg|DRUG: budesonide-MMX® 9 mg|DRUG: Placebo|DRUG: Asacol® 400 mg |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2008-06 |
|---|---|
| Primary Completion Date | 2010-05 |
| Completion Date | 2010-06 |